What is Harrow's operating income?

Harrow's total operating income in 2025 was $30.52 million, based on the following breakdown: Total Gross Profit: $204.37 million Total Operating Expenses: $173.85 million

Harrow (HROW) Financials

$34.48 -2.10 (-5.74%)

Closing price 09/11/2026 04:00 PM Eastern

Extended Trading

$34.94 +0.46 (+1.33%)

As of 09/11/2026 07:41 PM Eastern

Compare

Annual Income Statements for Harrow

This table shows Harrow's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-16	-19	-12	15	0.17	-3.36	-18	-14	-24	-17	-5.14
Consolidated Net Income / (Loss)	-16	-19	-12	15	-0.13	-3.42	-18	-14	-24	-17	-5.14
Net Income / (Loss) Continuing Operations	-16	-19	-12	15	-0.13	-3.42	-18	-14	-24	-17	-5.14
Total Pre-Tax Income	-16	-19	-13	15	-0.12	-3.42	-18	-14	-24	-17	-1.37
Total Operating Income	-15	-16	-12	-5.22	-4.80	0.39	1.61	1.92	0.43	8.82	31
Total Gross Profit	4.51	10	13	25	34	34	54	63	91	150	204
Total Revenue	9.72	20	27	41	51	49	72	89	130	200	272
Operating Revenue	9.72	20	27	41	51	49	72	89	130	200	272
Total Cost of Revenue	5.21	9.83	14	17	17	14	18	25	40	49	68
Operating Cost of Revenue	5.21	9.83	14	17	17	14	18	25	40	49	68
Total Operating Expenses	19	26	25	30	39	34	53	61	90	142	174
Selling, General & Admin Expense	13	18	25	29	33	31	41	58	83	129	153
Research & Development Expense	0.33	0.74	0.41	0.83	2.08	2.41	11	3.05	6.65	12	21
Impairment Charge	0.00	0.30	-	0.00	4.04	0.36	0.25	0.00	0.38	0.25	0.00
Total Other Income / (Expense), net	-1.08	-3.32	-0.76	20	4.68	-3.80	-19	-16	-24	-26	-32
Interest Expense	1.11	4.74	3.03	2.73	2.50	2.24	6.19	7.24	27	23	32
Interest & Investment Income	-	0.00	3.51	23	6.55	3.26	-10	-2.91	3.09	-3.17	0.00
Other Income / (Expense), net	0.03	1.42	-1.24	-0.29	0.63	-4.82	-3.17	-5.77	-0.44	-0.19	0.05
Income Tax Expense	0.00	-0.11	-0.94	0.00	0.01	0.00	0.13	0.08	0.70	0.16	3.77
Basic Earnings per Share	($1.66)	($1.50)	($0.60)	$0.67	$0.01	($0.13)	($0.69)	($0.51)	($0.75)	($0.49)	($0.14)
Weighted Average Basic Shares Outstanding	9.58M	12.74M	20.03M	21.92M	25.32M	25.90M	26.76M	27.46M	32.62M	35.65M	36.76M
Diluted Earnings per Share	($1.66)	($1.50)	($0.60)	$0.61	$0.01	($0.13)	-	($0.51)	($0.75)	($0.49)	($0.14)
Weighted Average Diluted Shares Outstanding	9.58M	12.74M	20.03M	23.81M	26.47M	25.90M	26.76M	27.46M	32.62M	35.65M	36.76M
Weighted Average Basic & Diluted Shares Outstanding	9.58M	12.74M	20.03M	24.69M	25.53M	25.90M	26.76M	29.97M	35.36M	35.65M	37.23M

This table shows Harrow's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Period end date	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026	6/30/2026
Net Income / (Loss) Attributable to Common Shareholders	-9.15	-14	-6.47	-4.22	6.78	-18	5.00	1.02	6.63	-28	-17
Consolidated Net Income / (Loss)	-9.15	-14	-6.47	-4.22	6.78	-18	5.00	1.02	6.63	-28	-17
Net Income / (Loss) Continuing Operations	-9.15	-14	-6.47	-4.22	6.78	-18	5.00	1.02	6.63	-28	-17
Total Pre-Tax Income	-9.68	-14	-5.82	-4.20	6.26	-18	5.00	1.02	10	-28	-17
Total Operating Income	-4.88	-6.93	1.53	1.32	13	-11	11	15	16	-22	-11
Total Gross Profit	25	24	36	37	53	32	48	54	71	27	50
Total Revenue	36	35	49	49	67	48	64	72	89	44	71
Operating Revenue	36	35	49	49	67	48	64	72	89	44	71
Total Cost of Revenue	11	11	13	12	14	16	16	18	18	17	20
Operating Cost of Revenue	11	11	13	12	14	16	16	18	18	17	20
Total Operating Expenses	30	31	35	36	40	44	36	39	55	49	61
Selling, General & Admin Expense	26	29	32	34	35	41	33	36	43	43	53
Research & Development Expense	3.34	2.15	3.05	2.27	4.76	3.03	2.87	3.32	12	5.90	8.07
Total Other Income / (Expense), net	-4.81	-6.64	-7.35	-5.52	-6.64	-6.55	-6.41	-14	-5.19	-5.50	-6.26
Interest Expense	5.12	5.42	5.47	5.53	6.38	6.55	6.41	14	5.19	5.50	6.26
Other Income / (Expense), net	-0.10	0.03	0.05	0.00	-0.26	-	-0.01	0.06	-0.01	-	0.00
Income Tax Expense	-0.54	-	0.66	0.02	-0.51	0.00	0.00	0.00	-	0.03	0.00
Basic Earnings per Share	($0.26)	($0.38)	($0.18)	($0.12)	$0.19	($0.50)	$0.14	$0.03	$0.19	($0.74)	($0.46)
Weighted Average Basic Shares Outstanding	32.62M	35.47M	35.62M	35.70M	35.65M	35.83M	36.79M	37.15M	36.76M	37.23M	37.35M
Diluted Earnings per Share	($0.26)	($0.38)	($0.18)	($0.12)	$0.19	($0.50)	$0.13	$0.03	$0.20	($0.74)	($0.46)
Weighted Average Diluted Shares Outstanding	32.62M	35.47M	35.62M	35.70M	35.65M	35.83M	38.85M	38.88M	36.76M	37.23M	37.35M
Weighted Average Basic & Diluted Shares Outstanding	35.36M	35.38K	35.48M	35.61M	35.65M	36.70M	37.00M	37.04M	37.23M	37.28M	37.49M

This table details how cash moves in and out of Harrow's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	-5.53	6.17	-6.60	2.62	-1.89	-0.65	38	54	-22	-27	26
Net Cash From Operating Activities	-11	-11	-8.80	0.69	0.95	-1.10	5.08	1.71	3.84	-22	44
Net Cash From Continuing Operating Activities	-11	-11	-11	0.69	0.95	-1.10	5.08	1.71	3.84	-22	44
Net Income / (Loss) Continuing Operations	-16	-19	-12	15	-0.13	-3.42	-18	-14	-24	-17	-5.14
Consolidated Net Income / (Loss)	-16	-19	-12	15	-0.13	-3.42	-18	-14	-24	-17	-5.14
Depreciation Expense	0.26	1.06	1.40	1.61	1.94	1.88	1.72	1.48	1.53	1.85	1.92
Amortization Expense	0.64	1.32	1.34	0.85	1.24	1.32	1.36	2.97	14	16	21
Non-Cash Adjustments To Reconcile Net Income	3.54	6.18	-0.26	-20	-0.38	5.39	20	17	20	22	26
Changes in Operating Assets and Liabilities, net	0.33	-0.68	0.70	3.44	-1.72	-6.27	-0.25	-5.57	-7.14	-45	0.19
Net Cash From Investing Activities	-5.13	-7.29	-0.96	-2.20	-1.83	-0.98	-19	-1.74	-153	-33	-5.46
Net Cash From Continuing Investing Activities	-2.09	-7.29	-0.96	-2.20	-1.83	-0.98	-19	-1.74	-153	-33	-5.46
Purchase of Property, Plant & Equipment	-1.52	-6.89	-0.77	-1.77	-1.47	-0.86	-1.79	-2.60	-1.46	-1.60	-0.89
Acquisitions	-3.61	-0.35	-0.25	-0.44	-0.37	-0.13	-0.08	-0.18	-0.02	-0.08	-4.36
Sale and/or Maturity of Investments	-	-	-	-	-	0.00	9.83	-	0.00	5.51	0.00
Other Investing Activities, net	-	0.00	-0.05	0.00	-	0.00	-27	1.00	-151	-37	-0.22
Net Cash From Financing Activities	11	25	4.93	4.13	-1.01	1.43	51	54	127	29	-13
Net Cash From Continuing Financing Activities	11	25	4.93	4.13	-1.01	1.43	51	54	127	29	-13
Repayment of Debt	-0.16	-0.46	-15	-0.74	-1.49	-1.51	-16	-0.02	-60	0.00	-233
Issuance of Debt	9.27	4.71	16	-	0.00	2.97	71	32	61	30	244
Issuance of Common Equity	0.40	21	4.06	0.64	-	-	0.00	23	138	0.00	0.00
Other Financing Activities, net	1.24	-0.09	0.18	4.23	0.49	-0.03	-3.16	-0.23	-13	-1.25	-25
Cash Interest Paid	0.64	1.37	1.54	2.10	1.97	1.79	4.82	6.48	19	21	19
Cash Income Taxes Paid	0.00	0.01	0.01	0.00	0.02	0.00	0.01	0.08	0.00	0.37	0.09

This table details how cash moves in and out of Harrow's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Period end date	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026	6/30/2026
Net Change in Cash & Equivalents	8.48	-5.55	2.43	1.63	-25	19	-14	21	-1.36	22	-11
Net Cash From Operating Activities	8.70	-4.63	-2.75	2.95	-18	20	-0.80	17	8.41	-8.99	-9.76
Net Cash From Continuing Operating Activities	8.70	-4.63	-2.75	2.95	-18	20	-0.80	17	8.41	-8.99	-9.76
Net Income / (Loss) Continuing Operations	-9.15	-14	-6.47	-4.22	6.78	-18	5.00	1.02	6.63	-28	-17
Consolidated Net Income / (Loss)	-9.15	-14	-6.47	-4.22	6.78	-18	5.00	1.02	6.63	-28	-17
Depreciation Expense	0.44	0.43	0.45	0.50	0.47	0.47	0.50	0.49	0.46	0.46	0.46
Amortization Expense	4.16	3.72	3.72	3.88	5.56	5.50	5.70	4.95	4.67	5.58	5.93
Non-Cash Adjustments To Reconcile Net Income	4.55	5.33	6.18	4.46	5.19	4.89	1.10	12	8.28	3.83	3.89
Changes in Operating Assets and Liabilities, net	8.70	-0.55	-6.63	-1.67	-36	27	-13	-1.69	-12	8.74	-2.76
Net Cash From Investing Activities	-0.20	-0.11	5.10	-0.60	-38	-0.21	-0.29	-0.23	-4.73	-18	-0.53
Net Cash From Continuing Investing Activities	-0.20	-0.11	5.10	-0.60	-38	-0.21	-0.29	-0.23	-4.73	-18	-0.53
Purchase of Property, Plant & Equipment	-0.19	-0.09	-0.34	-0.60	-0.56	-0.17	-0.17	-0.21	-0.34	-0.19	-0.49
Acquisitions	-0.02	-0.02	-0.06	0.01	-0.01	-0.04	-0.13	0.15	-4.34	-0.01	-0.04
Net Cash From Financing Activities	-0.02	-0.81	0.07	-0.72	30	0.02	-13	4.96	-5.04	49	-0.47
Net Cash From Continuing Financing Activities	-0.02	-0.81	0.07	-0.72	30	0.02	-13	4.96	-5.04	49	-0.47
Repayment of Debt	-	-	-0.10	-	0.10	0.00	-	-232	-0.05	-0.11	-0.44
Other Financing Activities, net	-74	-0.81	0.17	-0.72	0.11	0.02	-13	-6.93	-5.00	0.03	-0.02
Cash Income Taxes Paid	-	0.00	-	-	0.37	0.04	-	-	0.06	0.00	2.28

This table presents Harrow's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	14	27	24	49	59	57	98	157	312	389	399
Total Current Assets	5.87	15	8.81	33	36	41	61	118	139	190	212
Cash & Equivalents	2.69	8.85	-	-	-	-	42	96	74	47	73
Accounts Receivable	0.84	2.92	1.53	1.91	2.01	2.66	4.47	6.25	36	116	111
Inventories, net	1.41	1.84	2.25	1.83	3.30	3.96	4.22	6.54	11	11	14
Prepaid Expenses	0.79	0.94	0.71	0.84	0.59	1.60	1.31	3.61	9.59	15	14
Plant, Property, & Equipment, net	2.66	7.30	6.22	6.38	5.38	3.87	3.14	3.49	3.52	3.73	3.26
Total Noncurrent Assets	5.60	5.20	8.90	10	18	13	35	36	169	196	184
Goodwill	2.47	2.23	2.23	2.23	0.33	0.33	0.33	0.33	0.33	0.33	0.33
Intangible Assets	3.14	2.97	2.86	3.06	2.34	2.52	17	26	162	187	176
Other Noncurrent Operating Assets	-	0.00	3.51	4.95	15	9.77	5.94	9.46	6.79	8.55	7.78
Total Liabilities & Shareholders' Equity	14	27	24	49	59	57	98	157	312	389	399
Total Liabilities	16	21	21	25	32	31	87	130	242	320	347
Total Current Liabilities	5.37	9.91	5.77	12	12	11	9.72	19	49	91	96
Short-Term Debt	0.50	4.43	0.60	2.53	1.77	3.90	0.28	0.72	-	0.50	0.89
Accounts Payable	3.41	3.54	3.89	6.25	7.70	3.93	6.34	14	25	41	42
Accrued Expenses	0.20	0.21	0.05	-	-	-	-	0.00	18	40	42
Current Deferred Revenue	-	-	0.03	0.12	0.06	0.07	0.02	0.11	0.08	0.04	0.79
Current Employee Benefit Liabilities	1.20	1.64	1.21	2.28	2.12	2.32	3.09	4.03	5.45	9.50	10
Total Noncurrent Liabilities	10	11	16	13	19	20	78	112	192	228	251
Long-Term Debt	8.34	7.94	14	12	12	12	72	104	186	220	243
Other Noncurrent Operating Liabilities	0.76	0.72	0.80	0.80	7.14	7.45	6.01	0.00	6.52	8.79	7.91
Total Equity & Noncontrolling Interests	-1.39	6.43	2.62	25	27	27	11	27	70	69	52
Total Preferred & Common Equity	-1.39	6.43	2.62	25	28	27	11	28	71	70	52
Total Common Equity	-1.39	6.43	2.62	25	28	27	11	28	71	70	52
Common Stock	56	83	91	99	102	105	107	137	205	221	209
Retained Earnings	-58	-77	-89	-74	-74	-77	-95	-109	-134	-151	-157
Noncontrolling Interest	-	-	-	0.00	-0.29	-0.36	-0.36	-0.36	-0.36	-0.36	-0.36

This table presents Harrow's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026	Q2 2026
Period end date	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026	6/30/2026
Total Assets	217	224	286	296	307	352	364	345	363	420	417
Total Current Assets	52	60	110	125	139	147	170	155	178	226	229
Cash & Equivalents	19	23	66	69	71	73	67	53	74	95	84
Accounts Receivable	12	18	18	29	52	54	77	79	78	101	119
Inventories, net	9.09	8.56	8.92	11	9.43	10	11	12	13	16	17
Prepaid Expenses	3.60	3.81	9.01	9.72	7.01	11	15	12	13	14	9.95
Plant, Property, & Equipment, net	3.59	3.63	3.63	3.39	3.29	3.63	3.57	3.51	3.38	3.13	2.96
Total Noncurrent Assets	162	160	172	167	164	201	191	187	182	190	185
Goodwill	0.33	0.33	0.33	0.33	0.33	0.33	0.33	0.33	0.33	0.33	0.33
Intangible Assets	154	152	165	159	157	191	182	178	174	181	177
Other Noncurrent Operating Assets	7.34	7.16	6.97	6.97	6.77	9.38	8.34	8.16	7.97	8.64	7.39
Total Liabilities & Shareholders' Equity	217	224	286	296	307	352	364	345	363	420	417
Total Liabilities	196	202	211	235	248	294	308	296	316	391	402
Total Current Liabilities	18	23	19	42	54	95	187	249	65	91	102
Short-Term Debt	0.74	0.76	0.79	0.80	0.77	38	108	184	0.86	-	0.94
Accounts Payable	14	18	13	15	22	25	39	25	20	30	34
Accrued Expenses	-	-	-	21	25	25	31	32	35	51	55
Current Deferred Revenue	0.07	0.13	0.15	0.11	0.25	0.14	0.15	0.09	0.35	0.15	0.11
Current Employee Benefit Liabilities	3.10	4.29	5.32	5.03	5.72	7.19	7.61	6.82	9.52	9.23	12
Total Noncurrent Liabilities	178	179	192	194	195	199	121	47	251	300	300
Long-Term Debt	169	170	182	184	185	186	113	38	243	292	292
Capital Lease Obligations	7.14	6.94	6.74	6.72	6.54	9.50	-	-	-	-	7.42
Total Equity & Noncontrolling Interests	22	22	75	60	58	58	56	49	47	28	15
Total Preferred & Common Equity	22	22	76	61	59	58	56	50	47	29	15
Total Common Equity	22	22	76	61	59	58	56	50	47	29	15
Common Stock	138	143	201	208	212	216	226	214	210	213	217
Retained Earnings	-116	-120	-125	-147	-154	-158	-169	-164	-163	-184	-201
Noncontrolling Interest	-0.36	-0.36	-0.36	-0.36	-0.36	-0.36	-0.36	-0.36	-0.36	-0.36	-0.36

This table displays calculated financial ratios and metrics derived from Harrow's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	-	37,037,453.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	37,037,453.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	-0.14
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Net Operating Profit after Tax (NOPAT)	-10	-11	-8.51	-5.22	-3.36	0.27	1.13	1.34	0.30	6.18	21
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	0.12%	2.13%	7.21%
Earnings before Interest and Taxes (EBIT)	-15	-14	-13	-5.51	-4.17	-4.43	-1.56	-3.85	-0.01	8.64	31
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-14	-12	-11	-3.05	-0.99	-1.23	1.52	0.59	16	27	54
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-15	-18	-15	-5.14	-1.73	1.84	-5.28	-15	-136	-62	40
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	4.62	11	18	18	16	15	21	38	174	242	223
Increase / (Decrease) in Invested Capital	4.76	6.44	6.88	-0.08	-1.62	-1.57	6.41	17	136	69	-19
Book Value per Share	($0.14)	$0.49	$0.13	$1.06	$1.10	$1.06	$0.42	$1.01	$2.02	$1.96	$1.42
Tangible Book Value per Share	($0.72)	$0.09	($0.12)	$0.84	$0.99	$0.94	($0.23)	$0.05	($2.61)	($3.30)	($3.35)
Total Capital	7.46	20	18	39	41	43	83	139	256	289	296
Total Debt	8.84	14	15	15	14	16	72	112	186	220	244
Total Long-Term Debt	8.34	9.26	15	12	12	12	72	112	186	220	243
Net Debt	6.01	4.63	15	-6.89	-11	-12	10	10	103	173	171
Capital Expenditures (CapEx)	1.52	6.89	0.66	1.77	1.46	0.85	1.79	2.57	1.46	1.60	0.89
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-1.83	0.23	3.63	2.05	0.33	5.63	0.55	-1.51	7.37	52	43
Debt-free Net Working Capital (DFNWC)	1.00	9.28	3.63	23	26	34	51	100	90	99	116
Net Working Capital (NWC)	0.50	4.85	3.03	21	24	30	51	100	90	98	115
Net Nonoperating Expense (NNE)	5.52	7.97	3.47	-20	-3.23	3.69	19	15	25	24	26
Net Nonoperating Obligations (NNO)	6.01	4.63	15	-6.89	-11	-12	10	10	103	173	171
Total Depreciation and Amortization (D&A)	0.89	2.38	2.74	2.46	3.18	3.20	3.07	4.45	16	19	23
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($1.66)	($1.50)	$0.60	$0.67	$0.01	($0.13)	($0.69)	($0.51)	($0.75)	($0.49)	($0.14)
Adjusted Weighted Average Basic Shares Outstanding	13.11M	18.63M	20.78M	21.92M	25.32M	25.90M	27.03M	27.46M	32.62M	35.65M	36.76M
Adjusted Diluted Earnings per Share	($1.66)	($1.50)	$0.60	$0.61	$0.01	($0.13)	($0.69)	$0.00	($0.75)	($0.49)	($0.14)
Adjusted Weighted Average Diluted Shares Outstanding	13.11M	18.63M	20.78M	23.81M	26.47M	25.90M	27.03M	29.97M	32.62M	35.65M	36.76M
Adjusted Basic & Diluted Earnings per Share	($1.66)	($1.50)	$0.60	$0.00	$0.00	$0.00	($0.69)	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	9.58M	12.74M	20.03M	24.69M	25.53M	25.98M	26.76M	29.97M	35.36M	35.65M	37.23M
Normalized Net Operating Profit after Tax (NOPAT)	-10	-11	-8.51	-3.65	-0.53	0.52	1.30	1.34	0.57	6.35	21
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-

This table displays calculated financial ratios and metrics derived from Harrow's official financial filings.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Period end date	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026	6/30/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	37,037,453.00	37,229,705.00	37,275,107.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	37,037,453.00	37,229,705.00	37,275,107.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	0.18	-0.74	-0.46
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	78.83%	32.50%	46.22%	43.75%	83.83%	38.29%	30.25%	45.44%	-	-7.59%	10.85%
EBITDA Growth	-114.33%	-158.73%	-10.93%	0.67%	5,065.16%	-83.87%	205.96%	299.51%	-	-204.69%	-126.53%
EBIT Growth	-434.79%	-657.06%	-27.51%	-14.46%	354.03%	-62.74%	623.54%	1,017.58%	-	-96.58%	-196.53%
NOPAT Growth	-91.93%	-672.56%	-34.95%	-24.25%	509.01%	-62.12%	965.27%	1,494.79%	-	-96.58%	-167.53%
Net Income Growth	-967.11%	-104.20%	-53.06%	3.89%	174.08%	-31.07%	177.17%	124.17%	-	-55.24%	-445.75%
EPS Growth	0.00%	-72.73%	-28.57%	7.69%	173.08%	-31.58%	172.22%	125.00%	-	-48.00%	-453.85%
Operating Cash Flow Growth	334.27%	43.66%	-160.14%	344.29%	-304.45%	524.98%	70.76%	462.11%	-	-145.72%	-1,114.82%
Free Cash Flow Firm Growth	-660.71%	94.51%	93.79%	83.79%	60.81%	-350.17%	-216.86%	164.52%	-	26.30%	23.73%
Invested Capital Growth	361.39%	2.63%	5.74%	14.04%	39.51%	19.49%	21.66%	-0.91%	-	7.43%	6.07%
Revenue Q/Q Growth	6.10%	-4.86%	41.50%	0.65%	35.68%	-28.43%	33.27%	12.39%	-	-50.39%	59.86%
EBITDA Q/Q Growth	-106.63%	-630.32%	309.43%	-0.80%	227.24%	-127.04%	448.50%	15.09%	-	-177.44%	71.21%
EBIT Q/Q Growth	-421.18%	-38.73%	122.83%	-15.93%	853.81%	-188.87%	201.52%	29.86%	-	-241.69%	50.15%
NOPAT Q/Q Growth	-379.53%	-42.11%	122.08%	-13.66%	1,409.42%	-156.33%	245.11%	29.26%	-	-199.13%	50.15%
Net Income Q/Q Growth	-108.34%	-48.28%	52.28%	34.81%	260.59%	-362.36%	128.09%	-79.58%	-	-516.57%	37.43%
EPS Q/Q Growth	-100.00%	-46.15%	52.63%	33.33%	258.33%	-363.16%	126.00%	-76.92%	-	-470.00%	37.84%
Operating Cash Flow Q/Q Growth	819.87%	-153.22%	40.67%	207.47%	-702.47%	210.62%	-104.08%	2,165.75%	-	-206.91%	-8.49%
Free Cash Flow Firm Q/Q Growth	12.87%	93.28%	7.35%	-198.86%	-110.59%	22.80%	34.79%	160.85%	-	-217.07%	32.51%
Invested Capital Q/Q Growth	-9.26%	1.36%	2.07%	21.47%	11.01%	-13.18%	3.93%	-1.07%	-	-2.31%	2.62%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	68.91%	69.49%	74.38%	75.60%	78.85%	67.54%	74.54%	75.28%	-	61.18%	71.27%
EBITDA Margin	-1.03%	-7.94%	11.75%	11.58%	27.93%	-10.56%	27.61%	28.27%	-	-36.30%	-6.54%
Operating Margin	-13.41%	-20.03%	3.13%	2.68%	19.30%	-23.48%	17.90%	20.59%	-	-49.95%	-15.58%
EBIT Margin	-13.68%	-19.96%	3.22%	2.69%	18.91%	-23.48%	17.89%	20.67%	-	-49.95%	-15.58%
Profit (Net Income) Margin	-25.16%	-39.22%	-13.23%	-8.57%	10.14%	-37.17%	7.84%	1.42%	-	-62.44%	-24.44%
Tax Burden Percent	94.47%	100.00%	111.26%	100.48%	108.21%	100.00%	100.00%	100.00%	-	100.09%	100.00%
Interest Burden Percent	194.63%	196.54%	-369.16%	-316.98%	49.56%	158.30%	43.80%	6.89%	-	124.90%	156.90%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	-8.21%	0.00%	0.00%	0.00%	-	0.00%	0.00%
Return on Invested Capital (ROIC)	-11.58%	-11.20%	1.93%	1.55%	20.06%	-18.13%	20.48%	23.71%	-	-43.10%	-13.35%
ROIC Less NNEP Spread (ROIC-NNEP)	-21.68%	-17.76%	-3.68%	-2.17%	14.86%	-25.48%	16.06%	15.39%	-	-50.01%	-18.31%
Return on Net Nonoperating Assets (RNNOA)	-25.20%	-57.71%	-12.33%	-4.51%	29.34%	-59.10%	43.41%	48.68%	-	-208.16%	-110.17%
Return on Equity (ROE)	-36.78%	-68.91%	-10.40%	-2.96%	49.40%	-77.22%	63.89%	72.39%	-	-251.26%	-123.52%
Cash Return on Invested Capital (CROIC)	-128.46%	-5.71%	-9.00%	-16.18%	-30.02%	-16.12%	-14.48%	9.88%	-	-0.85%	-6.75%
Operating Return on Assets (OROA)	-7.59%	-10.79%	1.87%	1.43%	10.77%	-15.15%	12.50%	14.47%	-	-34.25%	-11.27%
Return on Assets (ROA)	-13.95%	-21.20%	-7.68%	-4.55%	5.77%	-23.99%	5.48%	1.00%	-	-42.81%	-17.68%
Return on Common Equity (ROCE)	-37.04%	-69.50%	-10.49%	-2.98%	49.65%	-77.70%	64.31%	72.88%	-	-253.37%	-124.89%
Return on Equity Simple (ROE_SIMPLE)	0.00%	-51.74%	-57.37%	-57.62%	0.00%	-38.43%	0.00%	0.00%	-	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	-3.41	-4.85	1.07	0.92	14	-7.86	11	15	16	-15	-7.70
NOPAT Margin	-9.39%	-14.02%	2.19%	1.88%	20.88%	-16.44%	17.90%	20.59%	-	-34.97%	-10.90%
Net Nonoperating Expense Percent (NNEP)	10.11%	6.56%	5.61%	3.72%	5.21%	7.35%	4.42%	8.32%	-	6.91%	4.96%
Return On Investment Capital (ROIC_SIMPLE)	-1.33%	-1.93%	-	-	4.82%	-2.84%	4.20%	5.08%	5.26%	-4.82%	-2.44%
Cost of Revenue to Revenue	31.09%	30.51%	25.62%	24.40%	21.15%	32.46%	25.46%	24.72%	-	38.82%	28.73%
SG&A Expenses to Revenue	72.10%	83.31%	65.01%	68.31%	52.06%	84.70%	52.14%	50.05%	-	97.80%	75.43%
R&D to Revenue	9.18%	6.21%	6.24%	4.61%	7.12%	6.33%	4.50%	4.64%	-	13.34%	11.42%
Operating Expenses to Revenue	82.32%	89.52%	71.25%	72.92%	59.55%	91.03%	56.64%	54.69%	-	111.14%	86.85%
Earnings before Interest and Taxes (EBIT)	-4.98	-6.90	1.58	1.33	13	-11	11	15	16	-22	-11
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-0.38	-2.75	5.75	5.71	19	-5.05	18	20	21	-16	-4.62
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	5.56	7.73	0.01	27.52	17.15	16.80	22.57	37.92	-	45.73	104.15
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00
Price to Revenue (P/Rev)	3.02	3.37	0.00	9.43	5.99	4.46	4.92	7.13	-	4.89	5.74
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	2.86	3.32	0.68	8.05	5.65	5.24	5.90	9.03	-	6.69	7.77
Enterprise Value to Revenue (EV/Rev)	3.81	4.21	0.79	10.38	6.85	5.18	5.66	7.81	-	5.62	6.53
Enterprise Value to EBITDA (EV/EBITDA)	30.20	64.78	14.68	210.63	49.94	43.95	34.93	37.46	-	35.37	87.14
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	158.31	255.89	91.24	70.68	-	76.77	0.00
Enterprise Value to NOPAT (EV/NOPAT)	1,644.29	0.00	0.00	0.00	221.41	348.49	127.96	100.22	-	109.67	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	129.19	78.53	1,067.97	410.82	0.00	526.33	319.44	110.44	-	99.30	287.84
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	90.97	-	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	2.64	3.18	3.31	4.04	3.18	3.94	4.51	5.22	-	10.30	20.26
Long-Term Debt to Equity	2.64	3.17	3.29	3.39	3.17	2.01	0.78	5.21	-	10.30	20.20
Financial Leverage	1.16	3.25	3.35	2.08	1.97	2.32	2.70	3.16	-	4.16	6.02
Leverage Ratio	4.81	6.28	6.61	4.79	5.02	5.67	6.06	6.85	-	9.28	11.88
Compound Leverage Factor	9.36	12.34	-24.42	-15.19	2.49	8.98	2.66	0.47	-	11.59	18.64
Debt to Total Capital	72.53%	76.10%	76.78%	80.18%	76.05%	79.74%	81.84%	83.93%	-	91.15%	95.30%
Short-Term Debt to Total Capital	0.00%	0.32%	0.31%	12.90%	0.17%	39.11%	67.66%	0.30%	-	0.00%	0.30%
Long-Term Debt to Total Capital	72.53%	75.78%	76.47%	67.27%	75.88%	40.63%	14.18%	83.64%	-	91.15%	95.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%	0.00%
Noncontrolling Interests to Total Capital	-0.14%	-0.14%	-0.14%	-0.12%	-0.12%	-0.13%	-0.13%	-0.12%	-	-0.11%	-0.11%
Common Equity to Total Capital	27.61%	24.05%	23.37%	19.94%	24.07%	20.39%	18.30%	16.19%	-	8.96%	4.82%
Debt to EBITDA	11.32	21.29	23.18	27.97	8.04	8.81	6.02	4.68	-	6.84	14.56
Net Debt to EBITDA	6.28	12.85	14.63	19.25	6.31	6.14	4.58	3.25	-	4.62	10.50
Long-Term Debt to EBITDA	11.32	21.20	23.09	23.47	8.02	4.49	1.04	4.66	-	6.84	14.52
Debt to NOPAT	616.13	-35.53	-32.22	-37.19	35.63	69.82	22.04	12.51	-	21.22	-156.29
Net Debt to NOPAT	341.79	-21.44	-20.33	-25.61	27.98	48.72	16.78	8.70	-	14.34	-112.69
Long-Term Debt to NOPAT	616.13	-35.38	-32.09	-31.21	35.55	35.57	3.82	12.47	-	21.22	-155.80
Altman Z-Score	1.09	1.23	0.15	3.30	2.62	1.62	2.05	3.95	-	2.25	2.63
Noncontrolling Interest Sharing Ratio	-0.73%	-0.87%	-0.89%	-0.53%	-0.51%	-0.61%	-0.66%	-0.68%	-	-0.84%	-1.11%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.83	3.00	2.60	1.55	2.08	0.91	0.62	2.72	-	2.48	2.24
Quick Ratio	2.41	2.51	2.30	1.33	1.79	0.77	0.53	2.32	-	2.14	1.98
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-139	-9.36	-8.68	-26	-55	-42	-27	17	34	-31	-21
Operating Cash Flow to CapEx	4,482.47%	-5,030.43%	-798.26%	488.58%	-3,203.42%	11,569.41%	-483.73%	7,899.05%	-	-4,635.05%	-1,986.76%
Free Cash Flow to Firm to Interest Expense	-27.19	-1.73	-1.59	-4.69	-8.56	-6.44	-4.29	1.21	-	-5.65	-3.35
Operating Cash Flow to Interest Expense	1.70	-0.85	-0.50	0.53	-2.79	3.00	-0.13	1.20	-	-1.64	-1.56
Operating Cash Flow Less CapEx to Interest Expense	1.66	-0.87	-0.56	0.42	-2.88	2.98	-0.15	1.19	-	-1.67	-1.64
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.55	0.54	0.58	0.53	0.57	0.65	0.70	0.70	-	0.69	0.72
Accounts Receivable Turnover	6.13	6.75	4.39	4.69	2.62	4.02	3.48	3.81	-	3.01	2.79
Inventory Turnover	4.55	4.21	4.95	4.87	4.57	5.04	5.52	5.53	-	5.11	5.17
Fixed Asset Turnover	37.16	39.76	44.54	46.63	55.03	61.19	66.96	71.39	-	80.23	85.17
Accounts Payable Turnover	2.07	2.90	2.22	2.44	1.49	2.00	2.43	2.80	-	2.01	2.48
Days Sales Outstanding (DSO)	59.59	54.05	83.17	77.91	139.55	90.90	104.86	95.86	-	121.13	130.71
Days Inventory Outstanding (DIO)	80.15	86.64	73.80	75.03	79.93	72.46	66.11	65.97	-	71.39	70.54
Days Payable Outstanding (DPO)	176.57	125.91	164.54	149.62	244.55	182.74	150.26	130.39	-	181.47	147.41
Cash Conversion Cycle (CCC)	-36.84	14.78	-7.57	3.32	-25.06	-19.38	20.71	31.44	-	11.04	53.84
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	174	176	180	218	242	210	218	216	223	226	232
Invested Capital Turnover	1.23	0.80	0.88	0.83	0.96	1.10	1.14	1.15	-	1.23	1.22
Increase / (Decrease) in Invested Capital	136	4.51	9.75	27	69	34	39	-1.98	-19	16	13
Enterprise Value (EV)	496	583	122	1,755	1,367	1,102	1,290	1,952	-	1,510	1,800
Market Capitalization	393	468	0.74	1,595	1,195	948	1,121	1,783	-	1,313	1,583
Book Value per Share	$2.02	$1.71	$1,654.33	$1.63	$1.96	$1.58	$1.35	$1.27	$1.42	$0.77	$0.41
Tangible Book Value per Share	($2.61)	($2.80)	($2,788.22)	($3.76)	($3.30)	($3.54)	($3.51)	($3.44)	($3.35)	($4.10)	($4.34)
Total Capital	256	252	251	291	289	277	271	290	296	320	316
Total Debt	186	192	192	233	220	221	222	244	244	292	301
Total Long-Term Debt	186	191	192	196	220	113	38	243	243	292	300
Net Debt	103	116	121	160	173	154	169	169	171	197	217
Capital Expenditures (CapEx)	0.19	0.09	0.34	0.60	0.56	0.17	0.17	0.21	0.34	0.19	0.49
Debt-free, Cash-free Net Working Capital (DFCFNWC)	7.37	8.53	16	17	52	24	37	39	43	40	44
Debt-free Net Working Capital (DFNWC)	90	85	87	90	99	91	90	113	116	135	128
Net Working Capital (NWC)	90	84	86	52	98	-17	-94	112	115	135	127
Net Nonoperating Expense (NNE)	5.74	8.72	7.54	5.14	7.18	9.92	6.41	14	8.97	12	9.57
Net Nonoperating Obligations (NNO)	103	116	121	160	173	154	169	169	171	197	217
Total Depreciation and Amortization (D&A)	4.60	4.16	4.18	4.38	6.03	6.18	6.19	5.44	5.14	6.04	6.39
Debt-free, Cash-free Net Working Capital to Revenue	5.66%	6.15%	10.14%	10.03%	25.83%	11.34%	16.10%	15.51%	-	15.00%	16.03%
Debt-free Net Working Capital to Revenue	69.23%	60.93%	56.18%	52.95%	49.50%	42.69%	39.37%	45.22%	-	50.23%	46.47%
Net Working Capital to Revenue	69.23%	60.36%	55.69%	30.78%	49.25%	-8.20%	-41.29%	44.87%	-	50.23%	46.13%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.26)	($0.38)	($0.18)	($0.12)	$0.19	($0.50)	$0.14	$0.03	$0.19	($0.74)	($0.46)
Adjusted Weighted Average Basic Shares Outstanding	32.62M	35.47M	35.62M	35.70M	35.65M	35.83M	36.79M	37.15M	36.76M	37.23M	37.35M
Adjusted Diluted Earnings per Share	($0.26)	($0.38)	($0.18)	($0.12)	$0.19	($0.50)	$0.13	$0.03	$0.20	($0.74)	($0.46)
Adjusted Weighted Average Diluted Shares Outstanding	32.62M	35.47M	35.62M	35.70M	35.65M	35.83M	38.85M	38.88M	36.76M	37.23M	37.35M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	35.36M	35.38K	35.48M	35.61M	35.65M	36.70M	37.00M	37.04M	37.23M	37.28M	37.49M
Normalized Net Operating Profit after Tax (NOPAT)	-3.41	-4.85	1.07	0.92	9.03	-7.86	7.99	10	11	-15	-7.70
Normalized NOPAT Margin	-9.39%	-14.02%	2.19%	1.88%	13.51%	-16.44%	12.53%	14.41%	-	-34.97%	-10.90%
Pre Tax Income Margin	-26.63%	-39.22%	-11.89%	-8.53%	9.37%	-37.17%	7.84%	1.42%	-	-62.39%	-24.44%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-0.97	-1.27	0.29	0.24	1.98	-1.72	1.78	1.07	-	-4.02	-1.76
NOPAT to Interest Expense	-0.67	-0.90	0.20	0.17	2.19	-1.20	1.78	1.07	-	-2.81	-1.23
EBIT Less CapEx to Interest Expense	-1.01	-1.29	0.23	0.13	1.90	-1.74	1.75	1.06	-	-4.05	-1.84
NOPAT Less CapEx to Interest Expense	-0.70	-0.91	0.13	0.06	2.10	-1.23	1.75	1.05	-	-2.85	-1.31
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%	0.00%

Financials Breakdown Chart

Key Financial Trends

Harrow’s financial profile shows substantial top-line expansion over the period covered, but profitability remains inconsistent. Second-quarter 2026 revenue increased 10.9% year over year to $70.7 million and was more than three times the $23.3 million reported in the second quarter of 2022. However, the company posted a $17.3 million net loss, or $0.46 per diluted share, reversing the $5.0 million profit reported in the restated second quarter of 2025.

Gross profit also grew year over year, rising to $50.4 million from $47.5 million, but the gross margin declined to approximately 71.3% from 74.5%. Operating expenses increased more rapidly, climbing 24.9% to $61.4 million, largely reflecting higher selling, general and administrative costs and research and development spending. The operating loss narrowed sequentially from $22.1 million in the first quarter of 2026 to $11.0 million in the latest quarter, but the company has not yet established a consistent pattern of operating profitability.

The balance sheet has expanded alongside the business, although leverage and cash-flow risks have increased. Cash and equivalents totaled $83.9 million at June 30, 2026, while total debt, including capital lease obligations, was approximately $301.6 million. Total equity fell to $14.8 million, down from $28.4 million at the end of the first quarter, and retained earnings remained deeply negative at $201.4 million. Accounts receivable increased to $118.6 million, which may support future cash collections but also places greater importance on working-capital management.

Revenue growth remains strong: Second-quarter 2026 revenue rose 10.9% year over year and more than tripled compared with the second quarter of 2022.
Gross profit continues to expand: Gross profit reached $50.4 million in Q2 2026, up from $47.5 million a year earlier and $16.8 million in Q2 2022.
Sequential losses improved: The operating loss narrowed to $11.0 million in Q2 2026 from $22.1 million in Q1, while the net loss improved from $27.6 million to $17.3 million.
Liquidity is higher than in prior years: Cash increased from $53.0 million in Q2 2025 and $22.8 million in Q2 2023 to $83.9 million in Q2 2026.
Working capital is sizable but volatile: Q2 2026 accounts receivable reached $118.6 million, while the company’s current ratio was approximately 2.2 times. The benefit of this liquidity depends on timely collections and continued access to financing.
Results have been uneven: Harrow was profitable in Q3 and Q4 2025 but reported losses in both Q1 and Q2 2026. Several earlier quarterly figures were subsequently restated, which makes long-term comparisons more difficult.
Operating cash flow remains negative: The company used $9.8 million of cash in operating activities during Q2 2026, following an $9.0 million operating cash outflow in Q1. This contrasts with positive operating cash flow in Q3 and Q4 2025.
Debt and interest costs are significant: Total debt and capital lease obligations were approximately $301.6 million, compared with roughly $192.3 million in Q2 2024. Interest expense reached $6.3 million in Q2 2026, limiting the benefit of gross profit growth.
Operating expenses are outpacing revenue: Q2 2026 operating expenses increased nearly 25% year over year, more than twice the rate of revenue growth, and pushed the company to an operating loss.
Equity provides a thin cushion: Total equity and noncontrolling interests declined to $14.8 million, while retained earnings remained negative. Intangible assets of $176.8 million also represented a substantial portion of total assets, increasing sensitivity to potential impairment charges.

09/12/26 06:10 PM ETAI Generated. May Contain Errors.

Harrow Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Harrow's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Harrow's net income appears to be on an upward trend, with a most recent value of -$5.14 million in 2025, falling from -$15.90 million in 2015. The previous period was -$17.48 million in 2024. View Harrow's forecast to see where analysts expect Harrow to go next.

Harrow's total operating income in 2025 was $30.52 million, based on the following breakdown:

Total Gross Profit: $204.37 million
Total Operating Expenses: $173.85 million

Over the last 10 years, Harrow's total revenue changed from $9.72 million in 2015 to $272.30 million in 2025, a change of 2,702.6%.

Harrow's total liabilities were at $347.39 million at the end of 2025, a 8.7% increase from 2024, and a 2,138.9% increase since 2015.

In the past 10 years, Harrow's cash and equivalents has ranged from $0.00 in 2017 to $96.27 million in 2022, and is currently $72.93 million as of their latest financial filing in 2025.

Over the last 10 years, Harrow's book value per share changed from -0.14 in 2015 to 1.42 in 2025, a change of -1,089.5%.

Related Companies

Financial statements for NASDAQ:HROW last updated on 8/10/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Harrow (HROW) Financials

Financials Breakdown Chart

Key Financial Trends

Harrow Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Harrow (HROW) Financials

Annual Income Statements for Harrow

Quarterly Income Statements for Harrow

Annual Cash Flow Statements for Harrow

Quarterly Cash Flow Statements for Harrow

Annual Balance Sheets for Harrow

Quarterly Balance Sheets for Harrow

Annual Metrics And Ratios for Harrow

Quarterly Metrics And Ratios for Harrow

Financials Breakdown Chart

Key Financial Trends

Harrow Financials - Frequently Asked Questions

When does Harrow's fiscal year end?

How has Harrow's net income changed over the last 10 years?

What is Harrow's operating income?

How has Harrow's revenue changed over the last 10 years?

How much debt does Harrow have?

How much cash does Harrow have?

How has Harrow's book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools